Visualizing vitreous in vitrectomy by triamcinolone

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 247, Issue 9, 2009, Pages 1153-1163

  Sakamoto, Taiji ^a   Ishibashi, Tatsuro ^b  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Complication; Endophtahlmitis; Epiretinal membrane; Intraocular pressure elevation; Posterior hyaloids; Triamcinolone acetonide; Vitrectomy

Indexed keywords

CORTICOSTEROID; CORTODOXONE; INDOMETACIN; POLYLACTIC ACID; TRIAMCINOLONE ACETATE; TRIAMCINOLONE ACETONIDE; TRIESENCE; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; BEHCET DISEASE; CATARACT EXTRACTION; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CORNEA INJURY; DIABETIC RETINOPATHY; DIAGNOSTIC IMAGING; DRUG SAFETY; ENDOPHTHALMITIS; EPIRETINAL MEMBRANE; EYE EXAMINATION; FIBROSIS; HIGH MYOPIA; HUMAN; INFLAMMATORY DISEASE; INTERMETHOD COMPARISON; INTRAOCULAR PRESSURE; INTRAOPERATIVE PERIOD; NONHUMAN; OPTIC NERVE ATROPHY; PRIORITY JOURNAL; RETINA DETACHMENT; RETINA MACULA HOLE; RETINA NECROSIS; RETINA TEAR; REVIEW; SARCOIDOSIS; SIDE EFFECT; TREATMENT INDICATION; UVEITIS; VISUAL ACUITY; VITRECTOMY; VITREORETINOPATHY; VITREOUS BODY; VITREOUS BODY DETACHMENT; VOGT KOYANAGI SYNDROME;

GLUCOCORTICOIDS; HUMANS; TRIAMCINOLONE ACETONIDE; VITRECTOMY; VITREOUS BODY;

EID: 68549134944     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-009-1118-2     Document Type: Review

References (118)

1. Michaels RG (1990) History of retinal detachment surgery. In: Michaels RG, Wilkinson CP, Rice TA (eds) Retinal detachment. Mosby, St. Louis, pp 243-323
2. Kelly NE, Wendel RT (1991) Vitreous surgery for idiopathic macular holes. Results of a pilot study. Arch Ophthalmol 109:654-649
3. Lewis H, Abrams GW, Blumenkranz MS, Campo RV (1992) Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction. Ophthalmology 99:753-759
4. Machemer R (1973) Vitrectomy in the management of severe diabetic retinopathies. Klin Monatsbl Augenheilkd 162:199-205
5. Norton EW, Machemer R (1971) New approach to the treatment of selected retinal detachments secondary to vitreous loss at cataract surgery. Am J Ophthalmol 72:705-707
6. Augustin AJ, Offermann I (2007) Scope and limititions of innovative vitrectomy systems. Klin Monatsbl Augenheilkd 224:707-715, doi: 10.1055/ s-2007-963518
7. Park DW, Sipperley JO, Sneed SR, Dugel PU, Jacobsen J (1999) Macular hole surgery with internal-limiting membrane peeling and intravitreous air. Ophthalmology 106:1392-1397, doi: 10.1016/S0161-6420(99)00730-7
8. Rodrigues EB, Penha FM, Furlani B, Meyer CH, Maia M, Farah ME (2008) Historical aspects and evolution of the application of vital dyes in vitreoretinal surgery and chromovitrectomy. Dev Ophthalmol 42:29-34, doi: 10.1159/000138911
9. Fujii GY, De Juan E Jr, Humayun MS, Pieramici DJ, Chang TS, Awh C, Ng E, Barnes A, Wu SL, Sommerville DN (2002) A new 25-gauge instrument system for transconjunctival sutureless vitrectomy surgery. Ophthalmology 109:1807-1812, doi: 10.1016/S0161-6420(02)01179-X
10. Enaida H, Hisatomi T, Goto Y, Hata Y, Ueno A, Miura M, Kubota T, Ishibashi T (2006) Preclinical investigation of internal limiting membrane staining and peeling using intravitreal brilliant blue G. Retina 26:623-630, doi: 10.1097/00006982-200607000-00006
11. Gandorfer A, Messmer EM, Ulbig MW, Kampik A (2001) Indocyanine green selectively stains the internal limiting membrane. Am J Ophthalmol 131:387-388, doi: 10.1016/S0002-9394(00)00924-7
12. Haritoglou C, Kreutzer T, Tadayoni R, Langhals H, May CA, Thaler S, Kampik A (2008) Staining and peeling of the internal limiting membrane using a fluorescent dye (Rhodamine 6 G). Br J Ophthalmol 92:1265-1268, doi: 10.1136/bjo.2008.141911
13. Kadonosono K, Itoh N, Uchio E, Nakamura S, Ohno S (2000) Staining of internal limiting membrane in macular hole surgery. Arch Ophthalmol 118:1116-1118
14. Peyman GA, Cheema R, Conway MD, Fang T (2000) Triamcinolone acetonide as an aid to visualization of the vitreous and the posterior hyaloid during pars plana vitrectomy. Retina 20:554-555
15. Sakamoto T, Miyazaki M, Hisatomi T, Nakamura T, Ueno A, Itaya K, Ishibashi T (2002) Triamcinolone-assisted pars plana vitrectomy improves the surgical procedures and decreases the postoperative blood-ocular barrier breakdown. Graefes Arch Clin Exp Ophthalmol 240:423-429, doi: 10.1007/s00417-002-0454-2
16. Sakamoto T, Soriano D, Nassaralla J, Murphy TL, Oganesian A, Spee C, Hinton DR, Ryan SJ (1995) Effect of intravitreal administration of indomethacin on experimental subretinal neovascularization in the subhuman primate. Arch Ophthalmol 113:222-226
17. Ishibashi T, Miki K, Sorgente N, Patterson R, Ryan SJ (1985) Effects of intravitreal administration of steroids on experimental subretinal neovascularization in the subhuman primate. Arch Ophthalmol 103:708-711
18. Giles CL (1974) Bulbar perforation during periocular injection of corticosteroids. Am J Ophthalmol 77:438-441
19. Hida T, Chandler D, Arena JE, Machemer R (1986) Experimental and clinical observations of the intraocular toxicity of commercial corticosteroid preparations. Am J Ophthalmol 101:190-195
20. McCuen BW II, Bessler M, Tano Y et al (1981) The lack of toxicity of intravitreally administered triamcinolone acetonide. Am J Ophthalmol 91:785-788
21. Zwaan J (1997) The long-term effects of an accidental injection of depot corticosteroids in an infant eye. Ophthalmic Surg Lasers 28:1017-1019
22. Sakamoto T, Hida T, Tano Y, Negi A, Takeuchi S, Ishibashi T, Inoue Y, Ohguro N, Okada AA (2007) Committee for Triamcinolone Acetonide for Ocular Disease in Japan. Survey of triamcinolone acetonide for ocular diseases in Japan. Nippon Ganka Gakkai Zasshi 111:936-945
23. Enaida H, Hata Y, Ueno A, Ishibashi T, Torii H, Sakamoto T (2004) Visualization of the Cloquet canal during triamcinolone-assisted vitrectomy. Arch Ophthalmol 122:1564-1565, doi: 10.1001/ archopht.122.10.1564
24. Fine HF, Spaide RF (2006) Visualization of the posterior precortical vitreous pocket in vivo with triamcinolone. Arch Ophthalmol 124:1663, doi: 10.1001/archopht.124.11.1663
25. Yamakiri K, Yamashita T, Miyazaki M, Doi N, Uemura A, Sakamoto T (2005) Fibrous proliferation of the pre-papillary canal in proliferative diabetic retinopathy: Cloquet's canal as a scaffold for proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 243:204-209, doi: 10.1007/s00417-004-1001-0
26. Doi N, Uemura A, Nakao K, Sakamoto T (2005) Vitreomacular adhesion and the defect in posterior vitreous cortex visualized by triamcinolone-assisted vitrectomy. Retina 25:742-745, doi: 10.1097/ 00006982-200509000-00009
27. Sonoda KH, Sakamoto T, Enaida H, Miyazaki M, Noda Y, Nakamura T, Ueno A, Yokoyama M, Kubota T, Ishibashi T (2004) Residual vitreous cortex after surgical posterior vitreous separation visualized by intravitreous triamcinolone acetonide. Ophthalmology 111:226-230, doi: 10.1016/ j.ophtha.2003.05.034
28. Matsumoto H, Yamanaka I, Hisatomi T, Enaida H, Ueno A, Hata Y, Sakamoto T, Ogino N, Ishibashi T (2007) Triamcinolone acetonide-assisted pars plana vitrectomy improves residual posterior vitreous hyaloid removal: ultrastructural analysis of the inner limiting membrane. Retina 27:174-179, doi: 10.1097/01.iae.0000237954.35359.fd
29. Faulborn J, Dunker S, Bowald S (1998) Diabetic vitreopathy-findings using the celloidin embedding technique. Ophthalmologica 212:369-376, doi: 10.1159/000027370
30. Sebag J, Buckingham B, Charles MA, Reiser K (1992) Biochemical abnormalities in vitreous of humans with proliferative diabetic retinopathy. Arch Ophthalmol 110:1472-1476
31. Sebag J (1996) Diabetic vitreopathy. Ophthalmology 103:205-206
32. Enaida H, Sakamoto T, Hisatomi T, Goto Y, Ishibashi T (2002) Morphological and functional damage of the retina caused by intravitreous indocyanine green in rat eyes. Graefes Arch Clin Exp Ophthalmol 240:209-213, doi: 10.1007/s00417-002-0433-7
33. Yamashita T, Uemura A, Sakamoto T (2008) Intraoperative characteristics of the posterior vitreous cortex in patients with epiretinal membrane. Graefes Arch Clin Exp Ophthalmol 246:333-337, doi: 10.1007/ s00417-007-0745-8
34. Chen TY, Yang CM, Liu KR (2006) Intravitreal triamcinolone staining observation of residual undetached cortical vitreous after posterior vitreous detachment. Eye 20:423-427, doi: 10.1038/sj.eye.6701892
35. Kishi S, Shimizu K (1994) Oval defect in detached posterior hyaloid membrane in idiopathic preretinal macular fibrosis. Am J Ophthalmol 118:451-456
36. Kimura H, Kuroda S, Nagata M (2004) Premacular cortical vitreous in patients with a rhegmatogenous retinal detachment. Retina 24:329-330, doi: 10.1097/00006982-200404000-00032
37. Enaida H, Hata Y, Ueno A, Nakamura T, Hisatomi T, Miyazaki M, Fujisawa K, Sakamoto T, Ishibashi T (2003) Possible benefits of triamcinolone-assisted pars plana vitrectomy for retinal diseases. Retina 223:764-770, doi: 10.1097/00006982-200312000-00003
38. Gandorfer A, Haritoglou C, Gandorfer A, Kampik A (2003) Retinal damage from indocyanine green in experimental macular surgery. Invest Ophthalmol Vis Sci 44:316-323, doi: 10.1167/iovs.02-0545
39. Kanda S, Uemura A, Yamashita T, Kita H, Yamakiri K, Sakamoto T (2004) Visual field defects after intravitreous administration of indocyanine green in macular hole surgery. Arch Ophthalmol 122:1447-1451, doi: 10.1001/archopht.122.10.1447
40. Yamashita T, Uemura A, Sakamoto T (2008) Long term effect of ICG after macular hole surgery. Retina 28:1228-1233, doi: 10.1097/ IAE.0b013e31817b6b2e
41. Enaida H, Sakamoto T, Ueno A, Nakamura T, Noda Y, Maruoka K, Ishibashi T (2003) Submacular deposition of triamcinolone acetonide after triamcinolone-assisted vitrectomy. Am J Ophthalmol 135:243-246, doi: 10.1016/S0002-9394(02)01917-7
42. Sakamoto T, Koga H, Noda Y, Ishibashi T (2002) Optic disk cup filled with triamcinolone. Retina 22:516-518, doi: 10.1097/ 00006982-200208000-00028
43. Bardak Y, Cekiç O, Tiǵ SU (2006) Comparison of ICG-assisted ILM peeling and triamcinolone-assisted posterior vitreous removal in diffuse diabetic macular oedema. Eye 20:1357-1359, doi: 10.1038/sj.eye.6702152
44. Horio N, Horiguchi M, Yamamoto N (2005) Triamcinolone-assisted internal limiting membrane peeling during idiopathic macular hole surgery. Arch Ophthalmol 123:96-99, doi: 10.1001/archopht.123.1.96
45. Kampougeris G, Cheema R, McPherson R, Gorman C (2007) Safety of Triamcinolone acetonide (TA)-assisted pars plana vitrectomy in macular hole surgery. Eye 21:591-594, doi: 10.1038/sj.eye.6702915
46. Kimura H, Kuroda S, Nagata M (2004) Triamcinolone acetonide-assisted peeling of the internal limiting membrane. Am J Ophthalmol 137:172-173, doi: 10.1016/S0002-9394(03)00782-7
47. Nomoto H, Shiraga F, Yamaji H, Fukuda K, Baba T, Takasu I, Ohtsuki H (2008) Macular hole surgery with triamcinolone acetonide-assisted internal limiting membrane peeling: One-year results. Retina 28:427-432, doi: 10.1097/IAE.0b013e31815ec2f1
48. Shah GK, Rosenblatt BJ, Blinder KJ, Grand MG, Smith M (2005) Triamcinolone-assisted internal limiting membrane peeling. Retina 25:972-975, doi: 10.1097/00006982-200512000-00003
49. Tognetto D, Zenoni S, Sanguinetti G, Haritoglou C, Ravalico G (2005) Staining of the internal limiting membrane with intravitreal triamcinolone acetonide. Retina 25:462-467, doi: 10.1097/ 00006982-200506000-00011
50. Kumagai K, Furukawa M, Ogino N, Larson E, Uemura A (2007) Long-term outcomes of macular hole surgery with triamcinolone acetonide-assisted internal limiting membrane peeling. Retina 27:1249-1254, doi: 10.1097/ IAE.0b013e3180ed45cc
51. Haritoglou C, Schüttauf F, Gandorfer A, Thaler S (2008) An experimental approach towards novel dyes for intraocular surgery. Dev Ophthalmol 42:141-152, doi: 10.1159/000139003
52. Rodrigues EB, Penha FM, Farah ME, de Paula Fiod Costa E, Maia M, Dib E, Bottós J, Freymuller E, Furlani B, Meyer CH, Magalhães O Jr, Lima-Filho AA, Safatle A (2009) Preclinical investigation of the retinal biocompatibility of six novel vital dyes for chromovitrectomy. Retina 29:497-510
53. Pendergast SD, Hassan TS, Williams GA et al (2000) Vitrectomy for diffuse diabetic macular edema associated with a taut premacular posterior hyloid. Am J Ophthalmol 130:178-186, doi: 10.1016/ S0002-9394(00)00472-4
54. Gruber D, Krebs I, Aggermann T, Neumaier B (2005) Vitrectomy for persistent diffuse diabetic macular edema. Stolba U, Binder S. Am J Ophthalmol 140:295-301, doi: 10.1016/j.ajo.2005.03.045
55. Higuchi A, Ogata N, Jo N, Wada M, Matsumura M (2006) Pars plana vitrectomy with removal of posterior hyaloid face in treatment of refractory diabetic macular edema resistant to triamcinolone acetonide. Jpn J Ophthalmol 50:529-531, doi: 10.1007/s10384-006-0366-5
56. LaHeij EC, Hendrikse F, Kessels AGH, Derhaag P (2001) Vitrectomy results in diabetic macular oedema without evident vitreomacular traction. Graefes Arch Clin Exp Ophthalmol 239:264-270, doi: 10.1007/s004170000251
57. Patel JI, Hykin PG, Schadt M, Luong V, Fitzke F, Gregor ZJ (2006) Pars plana vitrectomy with and without peeling of the inner limiting membrane for diabetic macular edema. Retina 26:5-13, doi: 10.1097/ 00006982-200601000-00002
58. Rosenblatt BJ, Shah GK, Sharma S, Bakal J (2005) Pars plana vitrectomy with internal limiting membranectomy for refractory diabetic macular edema without a taut posterior hyaloid. Graefes Arch Clin Exp Ophthalmol 243:20-25, doi: 10.1007/s00417-004-0958-z
59. Stefaniotou M, Aspiotis M, Kalogeropoulos C, Christodoulou A, Psylla M, Ioachim E, Alamanos I, Psilas K (2004) Vitrectomy results for diffuse diabetic macular edema with and without inner limiting membrane removal. Eur J Ophthalmol 14:137-143
60. Tachi N, Ogino N (1996) Vitrectomy for diffuse macular edema in cases of diabetic retinopathy. Am J Ophthalmol 122:258-260
61. Yamamoto T, Hitani K, Tsukahara T et al (2003) Early postoperative retinal thickness changes and complications after vitrectomy for diabetic macular edema. Am J Ophthalmol 135:14-19, doi: 10.1016/ S0002-9394(02)01819-6
62. Jumper JM, Embabi SN, Toth CA, McCuen BW II, Hatchell DL (2000) Electron immunocytochemical analysis of posterior hyaloid associated with diabetic macular edema. Retina 20:63-68, doi: 10.1097/ 00006982-200001000-00012
63. Gandorfer A, Messmer EM, Ulbig MW, Kampik A (2000) Resolution of diabetic macular edema after surgical removal of the posterior hyaloid and the inner limiting membrane. Retina 20:126-133, doi: 10.1097/ 00006982-200003000-00003
64. Ikuno Y, Sayanagi K, Ohji M, Kamei M, Gomi F, Harino S, Fujikado T, Tano Y (2004) Vitrectomy and internal limiting membrane peeling for myopic foveoschisis. Am J Ophthalmol 137:719-724
65. Le Rouic JF, Ducournau D, Becquet F (2006) Triamcinolone-assisted vitrectomy in the treatment of recurrent retinal detachment due to myopic macular hole. J Fr Ophtalmol 29:829-884, doi: 10.1016/ S0181-5512(06)73854-2
66. Yamamoto N, Ozaki N, Murakami K (2004) Triamcinolone acetonide facilitates removal of the epiretinal membrane and separation of the residual vitreous cortex in highly myopic eyes with retinal detachment due to a macular hole. Ophthalmologica 218:248-256, doi: 10.1159/ 000078615
67. Sakaguchi H, Ikuno Y, Choi JS, Ohji M, Tano T (2004) Multiple components of epiretinal tissues detected by triamcinolone and indocyanine green in macular hole and retinal detachment as a result of high myopia. Am J Ophthalmol 138:1079-1081,. doi: 10.1016/j.ajo.2004.06.078
68. Akiba J (1993) Prevalence of posterior vitreous detachment in high myopia. Ophthalmology 100:1384-1388
69. Takahashi M, Trempe CL, Maguire K, McMeel JW (1981) Vitreoretinal relationship in diabetic retinopathy: A biomicroscopic evaluation. Arch Ophthalmol 99:241-245
70. Takahashi M, Jalkh A, Hoskins J, Trempe CL, Schepens CL (1981) Biomicroscopic evaluation and photography of liquefied vitreous in some vitreoretinal disorders. Arch Ophthalmol 99:1555-1559
71. Diamond JG, Kaplan HJ (1979) Uveitis: Effect of vitrectomy combined with lensectomy. Ophthalmology 86:1320-1329
72. Kiryu J, Kita M, Tanabe T, Yamashiro K, Miyamoto N, Ieki Y (2001) Pars plana vitrectomy for cystoid mac ular edema secondary to sarcoid uveitis. Ophthalmology 108:1140-1144, doi: 10.1016/S0161-6420(01)00558-9
73. Ozertürk Y, Bardak Y, Durmuş M (2001) Vitreoretinal surgery in Behçet's disease with severe ocular complications. Acta Ophthalmol Scand 79:192-196, doi: 10.1034/j.1600-0420.2001.079002192.x
74. Stefánsson E (2009) Physiology of vitreous surgery. Graefes Arch Clin Exp Ophthalmol 247:147-163, doi: 10.1007/s00417-008-0980-7
75. Sonoda KH, Enaida H, Ueno A, Nakamura T, Kawano YI, Kubota T, Sakamoto T, Ishibashi T (2003) Pars plana vitrectomy assisted by triamcinolone acetonide for refractory uveitis: A case series study. Br J Ophthalmol 87:1010-1014, doi: 10.1136/bjo.87.8.1010
76. Furino C, Micelli Ferrari T, Boscia F, Cardascia N, Recchimurzo N, Sborgia C (2003) Triamcinolone-assisted pars plana vitrectomy for proliferative vitreoretinopathy. Retina 23:771-776, doi: 10.1097/ 00006982-200312000-00004
77. Ueno A, Enaida H, Hata Y, Hisatomi T, Nakamura T, Mochizuki Y, Sakamoto T, Ishibashi T (2007) Long-term clinical outcomes and therapeutic benefits of triamcinolone-assisted pars plana vitrectomy for proliferative vitreoretinopathy: A case study. Eur J Ophthalmol 17:392-398
78. Burk SE, Da Mata AP, Snyder ME, Schneider S, Osher RH, Cionni RJ (2003) Visualizing vitreous using Kenalog suspension. J Cataract Refract Surg 29:645-651, doi: 10.1016/S0886-3350(03)00016-6
79. Chang CJ, Chiang SY, Chen CL, Wang TY (2006) Clinical outcomes of combined sutureless vitrectomy with triamcinolone stain to manage vitreous loss resulting from posterior capsule rupture during phacoemulsification. J Cataract Refract Surg 32:2054-2059, doi: 10.1016/ j.jcrs.2006.07.023
80. Yamakiri K, Uchino E, Kimura K, Sakamoto T (2004) Intracameral triamcinolone helps to visualize and remove the vitreous body in anterior chamber in cataract surgery. Am J Ophthalmol 138:650-652, doi: 10.1016/j.ajo.2004.05.033
81. Yamakiri K, Sakamoto T, Noda Y, Nakahara M, Ogino N, Kubota T, Yokoyama M, Furukawa M, Sonoda Y, Yamada T, Doi N, Enaida H, Hata Y, Ishibashi T (2007) Reduced incidence of intraoperative complications in a multicenter controlled clinical trial of triamcinolone in vitrectomy. Ophthalmology 114:289-296, doi: 10.1016/j.ophtha.2006.07.044
82. Yamakiri K, Sakamoto T, Noda Y, Nakahara M, Ogino N, Kubota T, Yokoyama M, Furukawa M, Ishibashi T (2008) One-year results of a multicenter controlled clinical trial of triamcinolone in pars plana vitrectomy. Graefes Arch Clin Exp Ophthalmol 246:959-966, doi: 10.1007/ s00417-008-0829-0
83. Gillies MC, Sutter FK, Simpson JM, Larsson J, Ali H, Zhu M (2006) Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial. Ophthalmology 113:1533-1538, doi: 10.1016/ j.ophtha.2006.02.065
84. Jonas JB, Kreissig I, Degenring R (2003) Intraocular pressure after intravitreal injection of triamcinolone acetonide. Br J Ophthalmol 87:24-27, doi: 10.1136/bjo.87.1.24
85. Jones R 3rd, Rhee DJ (2006) Corticosteroid-induced ocular hypertension and glaucoma: A brief review and update of the literature. Curr Opin Ophthalmol 17:163-167
86. Sakamoto T, Enaida H, Kubota T, Nakahara M, Yamakiri K, Yamashita T, Yokoyama M, Hata Y, Murata T, Miyata K, Uemura A, Kimura W, Ishibashi T (2004) Incidence of acute endophthalmitis after triamcinolone-assisted pars plana vitrectomy. Am J Ophthalmol 138:137-138, doi: 10.1016/ j.ajo.2004.02.072
87. Moshfeghi DM, Kaiser PK, Scott IU et al (2003) Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol 136:791-796, doi: 10.1016/S0002-9394(03)00483-5
88. Eifrig CW, Scott IU, Flynn HW Jr, Smiddy WE, Newton J (2004) Endophthalmitis after pars plana vitrectomy: Incidence, causative organisms, and visual acuity outcomes. Am J Ophthalmol 138:799-802, doi: 10.1016/j.ajo.2004.06.035
89. Joondeph BC, Blanc JP, Polkinghorne PJ (2005) Endophthalmitis after pars plana vitrectomy: A New Zealand experience. Retina 25:587-589, doi: 10.1097/00006982-200507000-00008
90. Zhang S, Ding X, Hu J, Gao R (2003) Clinical features of endophthalmitis after vitreoretinal surgery. Yan Ke Xue Bao 19:39-43
91. Chen JK, Khurana RN, Nguyen QD, Do DV (2009) The incidence of endophthalmitis following transconjunctival sutureless 25- vs 20-gauge vitrectomy. Eye 23(4):780-784
92. Kunimoto DY, Kaiser RS, Wills Eye Retina Service (2007) Incidence of endophthalmitis after 20- and 25-gauge vitrectomy. Ophthalmology 114:2133-2137, doi: 10.1016/j.ophtha.2007.08.009
93. Scott IU, Flynn HW Jr, Dev S, Shaikh S, Mittra RA, Arevalo JF, Kychenthal A, Acar N (2008) Endophthalmitis after 25-gauge and 20-gauge pars plana vitrectomy: Incidence and outcomes. Retina 28:138-142, doi: 10.1097/IAE.0b013e31815e9313
94. Shimada H, Nakashizuka H, Hattori T, Mori R, Mizutani Y, Yuzawa M (2008) Incidence of endophthalmitis after 20- and 25-gauge vitrectomy causes and prevention. Ophthalmology 115:2215-2220, doi: 10.1016/ j.ophtha.2008.07.015
95. Parolini B, Romanelli F, Prigione G, Pertile G (2009) Incidence of endophthalmitis in a large series of 23-gauge and 20-gauge transconjunctival pars plana vitrectomy. Graefes Arch Clin Exp Ophthalmol 247(7):895-898
96. Ataka S, Kurita K, Wada S, Tayeya K, Shiraki K (2007) A case of mycotic endophthalmitis after triamcinolone acetonide-assisted pars plana vitrectomy. Int Ophthalmol 27:51-54, doi: 10.1007/s10792-007-9030-4
97. Yamashita T, Doi N, Sakamoto T (2004) Weak symptoms of bacterial endophthalmitis after a triamcinolone acetonide-assisted pars plana vitrectomy. Graefes Arch Clin Exp Ophthalmol 242:679-681, doi: 10.1007/ s00417-003-0834-2
98. Jaissle GB, Bartz-Schmidt KU, Szurman P (2008) Optic atrophy subsequent to epiretinal triamcinolone deposits in an eye following inner limiting membrane peeling. Ophthalmologe 105:575-577, doi: 10.1007/ s00347-007-1620-z
99. Lang Y, Leibu R, Shoham N, Miller B, Perlman I (2007) Evaluation of intravitreal kenalog toxicity in humans. Ophthalmology 114:724-731, doi: 10.1016/j.ophtha.2006.08.044
100. Chang YS, Wu CL, Tseng SH, Kuo PY, Tseng SY (2008) In vitro benzyl alcohol cytotoxicity: Implications for intravitreal use of triamcinolone acetonide. Exp Eye Res 86:942-950, doi: 10.1016/j.exer.2008.03.011
101. Chang YS, Wu CL, Tseng SH, Kuo PY, Tseng SY (2007) Cytotoxicity of triamcinolone acetonide on human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 48:2792-2798, doi: 10.1167/iovs.06-1146
102. Narayanan R, Mungcal JK, Kenney MC, Seigel GM, Kuppermann BD (2006) Toxicity of triamcinolone acetonide on retinal neurosensory and pigment epithelial cells. Invest Ophthalmol Vis Sci 47:722-728, doi: 10.1167/ iovs.05-0772
103. Oh J, Jung YS, Kim GS, Oh IK, Rho BK, Huh K (2007) The effect of short-term exposure of triamcinolone acetonide on fibroblasts and retinal pigment epithelial cells. Acta Ophthalmol Scand 85:786-790, doi: 10.1111/j.1600-0420.2007.00942.x
104. Szurman P, Sierra A, Kaczmarek R, Jaissle GB, Wallenfels-Thilo B, Grisanti S, Lüke M, Bartz-Schmidt KU, Spitzer MS (2007) Different biocompatibility of crystalline triamcinolone deposits on retinal cells in vitro and in vivo. Exp Eye Res 85:44-53, doi: 10.1016/ j.exer.2007.03.003
105. Yeung CK, Chan KP, Chiang SW, Pang CP, Lam DS (2003) The toxic and stress responses of cultured human retinal pigment epithelium (ARPE19) and human glial cells (SVG) in the presence of triamcinolone. Invest Ophthalmol Vis Sci 44:5293-5300, doi: 10.1167/iovs.03-0490
106. Kozak I, Cheng L, Mendez T, Davidson MC, Freeman WR (2006) Evaluation of the toxicity of subretinal triamcinolone acetonide in the rabbit. Retina 26:811-817, doi: 10.1097/01.iae.0000244255.22406.2f
107. Macky TA, Helmy D, El Shazly N (2007) Retinal toxicity of triamcinolones vehicl'e (benzyl alcohol): An electrophysiologic and electron microscopic study. Graefes Arch Clin Exp Ophthalmol 245:817-824, doi: 10.1007/s00417-006-0459-3
108. Maia M, Penha FM, Farah ME, Dib E, Príncipe A, Lima Filho AA, Magalhães O Jr, Freymüller E, Rodrigues EB (2008) Subretinal injection of preservative-free triamcinolone acetonide and supernatant vehicle in rabbits: An electron microscopy study. Graefes Arch Clin Exp Ophthalmol 246:379-388, doi: 10.1007/s00417-007-0718-y
109. Albini TA, Abd-El-Barr MM, Carvounis PE, Iyer MN, Lakhanpal RR, Pennesi ME, Chevez-Barrios P, Wu SM, Holz ER (2007) Long-term retinal toxicity of intravitreal commercially available preserved triamcinolone acetonide (Kenalog) in rabbit eyes. Invest Ophthalmol Vis Sci 48:390-395, doi: 10.1167/iovs.06-0145
110. Dierks D, Lei B, Zhang K, Hainsworth DP (2005) Electroretinographic effects of an intravitreal injection of triamcinolone in rabbit retina. Arch Ophthalmol 123:1563-1569, doi: 10.1001/archopht.123.11.1563
111. Ruiz-Moreno JM, Montero JA, Bayon A, Rueda J, Vidal M (2007) Retinal toxicity of intravitreal triamcinolone acetonide at high doses in the rabbit. Exp Eye Res 84:342-348, doi: 10.1016/j.exer.2006.10.006
112. Yu SY, Damico FM, Viola F, DAmico DJ, Young LH (2006) Retinal toxicity of intravitreal triamcinolone acetonide: A morphological study. Retina 26:531-536, doi: 10.1097/00006982-200605000-00006
113. Dyer D, Callanan D, Bochow T, Abraham P, Lambert HM, Lee SY, Schneiderman T, Potts SL, Walker TM (2009) Clinical evaluation of the safety and efficacy of preservative-free triamcinolone (triesence [triamcinolone acetonide injectable suspension] 40 mg/ml) for visualization during pars plana vitrectomy. Retina 29:38-45, doi: 10.1097/IAE.0b013e318188c6e2
114. Kaji Y, Hiraoka T, Okamoto F, Sato M, Hu B, Yamane N, Oshika T (2004) Visualizing the vitreous body in the anterior chamber using 11-deoxycortisol after posterior capsule rupture in an animal model. Ophthalmology 111:1334-1339, doi: 10.1016/j.ophtha.2003.11.011
115. Kaji Y, Hiraoka T, Okamoto F, Sato M, Oshika T (2005) Clinical application of 11-deoxycortisol in visualizing prolapsed vitreous body after posterior capsule rupture in cataract surgery. J Cataract Refract Surg 31:1133-1138, doi: 10.1016/j.jcrs.2004.10.059
116. Crum R, Szabo S, Folkman J (1985) A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment. Science 230:1375-1378, doi: 10.1126/science.2416056
117. Yamashita T, Sakamoto T, Yamakiri K, Miura M, Enaida H, Ueno A, Atsumi I, Matsuhisa K, Sakamoto Y, Kida T, Ishibashi T (2007) Polylactic acid for visualizing the vitreous body during vitrectomy. Invest Ophthalmol Vis Sci 48:3277-3282, doi: 10.1167/iovs.06-1020
118. Athanasiou KA, Agrawal CM, Barber FA et al (1998) Orthopaedic applications for PLA-PGA biodegradable polymers. Arthroscopy 14:726-737, doi: 10.1016/S0749-8063(98)70099-4